Abstract
The authors developed a strategy that includes a novel approach of induction full-dose chemotherapy followed by traditional chemoradiation as a neoadjuvant therapy for pancreatic cancer. Here they report the results of a phase I/II trial of gemcitabine, cisplatin, and 5-FU for patients with advanced gastrointestinal malignancies.
Original language | English (US) |
---|---|
Pages (from-to) | 697-709 |
Number of pages | 13 |
Journal | Surgical Oncology Clinics of North America |
Volume | 13 |
Issue number | 4 |
DOIs | |
State | Published - Oct 2004 |
ASJC Scopus subject areas
- Surgery
- Oncology